Design, synthesis and anti-cancer activity of novel 1,2,3-triazole hybrids of erlotinib against cervical cancer via MAPK signaling pathway
Abstract Cervical cancer, a common malignant tumor of the female reproductive system, ranks fourth in incidence and mortality among female cancers globally, which highlights the urgent need for new therapeutic agents to improve treatment outcomes. In this study, 16 new erlotinib-1,2,3-triazole deriv...
Saved in:
| Main Authors: | Lan Wang, Xixi Hou, Mengmeng Huang, Baoyu He, Longfei Mao, Zhengwei Hu, Ling Li, Jingjing Guo, Lizeng Peng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-09168-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botriomicosis asociada a tratamiento con erlotinib en una paciente con adenocarcinoma de pulmón
by: Claudia Montoya, et al.
Published: (2019-08-01) -
Mechanistic Insights and Anti-cancer Activity of 2H-benzo[b][1,4]oxazin-3(4H)-one Linked 1,2,3-Triazoles in Human Cancer Cells
by: Qingying Liu, et al.
Published: (2025-06-01) -
Exploring the Anticancer Properties of 1,2,3-Triazole-Substituted Andrographolide Derivatives
by: Joana R. L. Ribeiro, et al.
Published: (2025-05-01) -
LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis
by: Maryam Hejazi, et al.
Published: (2025-08-01) -
EGFR tyrosine kinase inhibitor: design, synthesis, characterization, biological evaluation, and molecular docking of novel 1,3,4-oxadiazole, thio-methyl, and 1,2,3-triazole hybrids
by: Asma Khalaf Alshamari, et al.
Published: (2025-07-01)